[Long term treatment of arteriosclerotically induced circulatory disorders of the retina and choroid with vitamins A + E as well as a nicotinic acid derivative].
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002829:Choroid; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D005654:Fundus Oculi; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage*; D012160:Retina; D014665:Vasodilator Agents / Q000008:administration & dosage*; D014801:Vitamin A / Q000008:administration & dosage*; D014810:Vitamin E / Q000008:administration & dosage*
D011725:Pyridines; D014665:Vasodilator Agents; D014801:Vitamin A; D014810:Vitamin E
Langzeitbehandlung arteriosklerotisch bedingter Durchblutungsstörungen der Netz- und Aderhaut mit den Vitaminen A + E sowie einem Nikotinsäurederivat.